A portfolio proven in Europe’s largest medical cannabis market
Materia has supplied pharmacies and wholesalers in Germany with medical cannabis flowers and extracts. The same standards now shape our UK portfolio: products selected for consistent genetics, cannabinoid profile and reliability of supply, manufactured by EU-GMP certified partners and distributed under GDP conditions.
Our range also includes products manufactured at our group’s own EU-GMP certified facility in Malta, operated by Alphafarma Operations Ltd. Having a sister company like this within the group gives us direct oversight of quality from cultivation to pharmacy.
Full product specifications, cannabinoid profiles and documentation are available to healthcare professionals and trade partners on request.
Trade enquiries: We work exclusively with licensed pharmacies, wholesalers and clinical partners.
The name Materia – a reference back to the ‘materia medica‘, comes from Latin and can be translated as source or talent. It is also our motivation to draw the best from what nature provides us with and to make optimal medical use of the diverse natural active ingredients of the cannabis plant.
With high-quality cannabis products, we want to enable patients to live a life that is no longer dominated by their symptoms.
Materia Deutschland GmbH was founded in Hamburg in June 2018 and we launched in the UK in 2026. We specialize in intra-EU import and GDP-compliant distribution of high-quality medical cannabis products manufactured by qualified EU-GMP-certified partners. Materia is a supporting member of the German Association of Cannabis-Supplying Pharmacies (VCA).
Medicinal cannabis has been available on prescription in the UK since November 2018.
One of the largest areas of application is pain therapy, but there are also many other indications in which medicinal cannabis can be used.